NEUROPEPTIDE-Y AND DIFFERENTIAL SYMPATHETIC CONTROL OF SPLENIC BLOOD-FLOW AND CAPACITANCE FUNCTION IN THE PIG AND DOG

被引:15
|
作者
MODIN, A
PERNOW, J
LUNDBERG, JM
机构
[1] Department of Pharmacology, Karolinska Institute, Stockholm, S-104 01
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 1993年 / 147卷 / 01期
关键词
HEMATOCRIT; NEUROPEPTIDE-Y; NORADRENALINE; SPLEEN; SPLENIC BLOOD FLOW; SPLENIC CAPACITANCE FUNCTION; SPLENIC CAPSULE;
D O I
10.1111/j.1748-1716.1993.tb09468.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The roles of different mediators in the sympathetic regulation of the pig and dog spleens were investigated using a preparation with intact vascular perfusion in vivo. Sympathetic nerve stimulation caused overflow of neuropeptide Y-like immunoreactivity (NPY-LI) and noradrenaline (NA), arterial vasoconstriction, increase in venous blood flow and haematocrit. The dog spleen responded to single impulse stimulation, whereas more prolonged stimulation was required to elicit vascular responses in the pig spleen. Furthermore, the maximal splenic capacitance response was about 10 times larger in the dog than in the pig. After depletion of neuronal NA content by reserpine combined with preganglionic denervation, about 70% of the splenic arterial vasoconstrictor responses in the dog and pig still remained at 5 Hz stimulation. Fifty per cent of the capacitance response evoked by nerve stimulation still remained in the pig while in the dog spleen the capacitance response was virtually abolished after reserpine. The stimulation-evoked overflow of NPY-LI in pig spleen was increased several fold after reserpine treatment as compared to controls reaching levels in the venous effluent where exogenous NPY evokes vasoconstriction. In the dog spleen, overflow of NPY-LI was only observed after reserpine. Administration of NA caused arterial vasoconstriction with an initial increase in venous blood flow while NPY mainly reduced arterial blood flow. It is concluded that NA is involved in both the splenic arterial vasoconstriction and the capacitance responses while a non-adrenergic splenic vasoconstriction at least in the pig may be mediated by NPY.
引用
收藏
页码:15 / 25
页数:11
相关论文
共 50 条
  • [1] NEUROPEPTIDE-Y IN RELATION TO SYMPATHETIC CONTROL OF RENAL BLOOD-FLOW
    PERNOW, J
    LUNDBERG, JM
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 2039 - 2040
  • [2] NEUROPEPTIDE-Y AND CEREBRAL BLOOD-FLOW
    TUOR, UI
    EDVINSSON, L
    MCCULLOCH, J
    [J]. LANCET, 1985, 1 (8440): : 1271 - 1271
  • [3] RELEASE AND VASOCONSTRICTOR EFFECTS OF NEUROPEPTIDE-Y IN RELATION TO NON-ADRENERGIC SYMPATHETIC CONTROL OF RENAL BLOOD-FLOW IN THE PIG
    PERNOW, J
    LUNDBERG, JM
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1989, 136 (04): : 507 - 517
  • [4] SYMPATHETIC REGULATION OF SKELETAL-MUSCLE BLOOD-FLOW IN THE PIG - A NONADRENERGIC COMPONENT LIKELY TO BE MEDIATED BY NEUROPEPTIDE-Y
    MODIN, A
    PERNOW, J
    LUNDBERG, JM
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 148 (01): : 1 - 11
  • [5] NEUROPEPTIDE-Y REDUCES DOG CORONARY BLOOD-FLOW BY INCREASED SMALL VESSEL RESISTANCE
    CLARKE, J
    LARKIN, S
    OSINAWA, O
    DAVIES, GJ
    TAYLOR, K
    MASERI, A
    [J]. CLINICAL SCIENCE, 1987, 73 : P6 - P6
  • [6] NEUROPEPTIDE-Y REDUCES OVARIAN BLOOD-FLOW IN THE RABBIT
    JORGENSEN, JC
    SEJRSEN, P
    [J]. PEPTIDES, 1990, 11 (03) : 451 - 454
  • [7] NEUROPEPTIDE-Y (NPY) AND SYMPATHETIC CONTROL OF BLOOD-FLOW IN ORAL-MUCOSA AND DENTAL-PULP IN THE CAT
    EDWALL, B
    GAZELIUS, B
    FAZEKAS, A
    THEODORSSONNORHEIM, E
    LUNDBERG, JM
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1985, 125 (02): : 253 - 264
  • [8] ENDOGENOUS NEUROPEPTIDE-Y REGULATES THYROID BLOOD-FLOW
    MICHALKIEWICZ, M
    HUFFMAN, LJ
    DEY, M
    HEDGE, GA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05): : E699 - E705
  • [9] EFFECT OF NEUROPEPTIDE-Y ON TRANSMURAL DISTRIBUTION OF MYOCARDIAL BLOOD-FLOW
    GUTTERMAN, DD
    BARBER, CE
    MORGAN, DA
    [J]. CIRCULATION, 1990, 82 (04) : 336 - 336
  • [10] EFFECT OF NEUROPEPTIDE-Y ON TRANSMURAL DISTRIBUTION OF MYOCARDIAL BLOOD-FLOW
    GUTTERMAN, DD
    BARBER, CE
    MORGAN, DA
    [J]. CLINICAL RESEARCH, 1990, 38 (03): : A829 - A829